Drug‐induced immune‐mediated thrombocytopenia secondary to durvalumab use
Author:
Affiliation:
1. Department of Internal Medicine University of Virginia Charlottesville VA USA
2. Department of Pharmacy University of Virginia Charlottesville VA USA
Publisher
Wiley
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.4227
Reference21 articles.
1. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
2. Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
3. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
4. Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
5. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review;International Immunopharmacology;2024-03
2. PD-1/PD-L1 Inhibitor - Related Adverse Events and Their Management in Breast Cancer;Journal of Cancer;2024
3. Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report;Translational Lung Cancer Research;2022-11
4. Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor;The American Journal of Emergency Medicine;2022-06
5. IgA Nephropathy Secondary to Ipilimumab Use;Case Reports in Nephrology and Dialysis;2021-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3